Ambros Therapeutics launches with $125M to advance neridronate, a non-opioid therapy for CRPS-1. See how this Phase 3-ready ...

Abiogen Pharma is a recognized leader in the discovery and development of bisphosphonates including the advancement of neridronate. Neridronate was approved in Italy based on the safety and efficacy ...

Bisphosphonates reduced complex regional pain syndrome pain intensity in the short term but not other time scales.

CRPS typically develops in a limb after injury or surgery and can lead to long-term disability. It causes severe, persistent pain that is often far worse than the initial injury, along with swelling ...

Imagine stubbing your toe and feeling like it's been set on fire... for months. Now imagine that burning sensation spreading to your entire leg, and instead of easing over time, it gets worse. That’s ...